Literature DB >> 6977823

Immunological subsets in human B-cell lymphomas.

T Godal, T Lindmo, P F Marton, T O Landaas, R Langholm, J Høie, A Foss Abrahamsen.   

Abstract

Fifty human B-cell lymphomas have been studied with regard to surface markers (surface immunoglobulins (sIg) and complement receptors (CR)), capping of sIg, and relative amounts of sIg by single-cell flow cytometry. The results show that these lymphomas can be subdivided into distinct immunological subsets. Whereas one histological subgroup (lymphocytic) consisted of only one immunological subtype, others were heterogeneous with regard to immunological subtypes. This was most striking in nodular lymphomas of germinal centre cell origin (centroblastic/centrocytic). Our studies provide further evidence for the existence of a large number of subsets in the B-cell compartment of the immune system, sIgD was only found in association with sIgM. The relative amounts of sIgD varied, especially in nodular lymphomas. A discrepancy between capping of sIgM and sIgD was also found in some lymphomas belonging to this group. These findings together with other observations suggest that sIgD plays a role in B-cell maturation and differentiation events taking place in germinal centres and becomes lost during this process. A close association was found between the presence of CR and capping of sIgM but not capping of sIgD or sIgG. Nodular lymphomas expressing sIgG only, lacked CR. These findings suggest that CR may become lost during maturation and differentiation processes also taking place in germinal centres. Lymphoplasmacytoid lymphomas, which show morphological evidence of differentiation towards plasma cells, could be subdivided into three immunological subsets, indicating that plasma cell maturation may take place from different subsets of B cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6977823

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  BCG-induced suppressor T cells optimal conditions for in vitro induction and mode of action.

Authors:  A S Mustafa; T Godal
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

2.  Differences in modifications of cytoplasmic free Ca2+ concentration and 86Rb+ influx in human neoplastic B cells by antibodies to mu- relative to delta-Ig heavy chains.

Authors:  R Heikkilä; E Ruud; S Funderud; T Godal
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

3.  Induction of maturation of human B-cell lymphomas in vitro. Morphologic changes in relation to immunoglobulin and DNA synthesis.

Authors:  K Beiske; E Ruud; A Drack; P F Marton; T Godal
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

4.  Surface IgG subclasses in human B cell lymphomas as revealed by monoclonal antibodies.

Authors:  E B Smeland; R Jefferis; T Godal
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Triggering of monoclonal human lymphoma B cells with antibodies to IgM heavy chains: differences of response obtained with monoclonal as compared to polyclonal antibodies.

Authors:  T Godal; E Ruud; R Heikkilä; S Funderud; T Michaelsen; R Jefferis; N R Ling; K Hildrum
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

6.  Routine flow cytometric diagnosis of lymphoproliferative disorders.

Authors:  I G Barr; B H Toh
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

7.  Sézary cells with an unusual phenotype, their modulation with 12-O-tetradecanoyl phorbol-13-acetate (TPA) in vitro, and their relationship to T-cell development.

Authors:  S Kvaløy; T Lindmo; C Davies; F Wisløff; T Godal
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.